Journal
PEDIATRIC BLOOD & CANCER
Volume 51, Issue 1, Pages 110-117Publisher
WILEY-LISS
DOI: 10.1002/pbc.21530
Keywords
central nervous system tumors; cognitive effects; pediatric; photon beam radiation; proton beam radiation; treatment modeling
Categories
Funding
- NCI NIH HHS [P30 CA021765, 5 P30 CA21765-28] Funding Source: Medline
Ask authors/readers for more resources
Background. To determine whether proton radiotherapy has clinical advantages over photon radiotherapy, we modeled the dose characteristics of both to critical normal tissue volumes using data from patients with four types of childhood brain tumors. Procedures. Three-dimensional imaging and treatment planning data, including targeted tumor and normal tissues contours, were acquired for 40 patients, 10 each with optic pathway glioma (OPG), craniopharyngioma (CR), infratentorial ependymoma (EP), or medulloblastoma (MB). Dose-volume data were collected for the entire brain, temporal lobes, cochlea, and hypothalamus from each patient. The data were averaged and compared based on treatment modality (protons vs. photons) using dose-cognitive effects models. Outcomes were estimated over 5 years. Results. Relatively small critical normal tissue volumes such as the cochlea and hypothalamus may be spared from radiation exposure when not adjacent to the primary tumor volume. Larger normal tissue volumes such as the supratentorial brain or temporal lobes receive less of the low and intermediate doses. When applied to longitudinal models of radiation dose-cognitive effects, these differences resulted in clinically significant higher IQ scores for patients with MB and CR and academic reading scores in patients with OPG. Extreme differences between proton and photon dose distributions precluded meaningful comparison of protons and photons for patients with EP. Conclusions. Differences in the overall dose distributions, as indicated by modeling changes in cognitive function, showed that a reduction in the lower-close volumes or mean dose would have long-term, clinical advantages for children with MB, CR, and OPC.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available